Please login to the form below

Not currently logged in
Email:
Password:

Sarah Verhoeff joins the board at Pan

UK advertising agency promotes its associate director

Pan Sarah VerhoeffSarah Verhoeff has been appointed to the board of UK-based creative agency Pan.

Verhoeff is a relative newcomer to Pan, having joined as associate director in January from Havas Life (then known as Euro RSCG Life), where she was business director at the UK office.

Pan managing director Jon Linscott said that the agency was delighted to promote Verhoeff, who has become 'an integral member of the team' and will be working on the development of HTML5 iPad detail aid builds under Pan's recently launched in-house capability.

“Since joining Pan she has clearly demonstrated her incredible expertise, deep thinking and skilful execution of client business as well as a very strong role in the development of the company and its people,” he said.

Verhoeff joins Emily Wigginton, director; Julia Straker, director of strategic brand planning; and Arron O'Hare, creative director, on the Pan board. Among her responsibilities will be leading key clients such as Otsuka/Lundbeck, Takeda, Astellas, UCB, GSK, Linscott told PMLiVE.

“This  appointment means that Pan now has a senior team with the right balance of skills and experience to ensure that we're exceeding client expectations when it comes to creating influential creativity for the brands for which we are responsible,” Linscott added.

26th September 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...